Correction to: Balkrishnan R, Rajagopalan R, Shenolikar RA et al. Healthcare costs and prescription adherence with introduction of thiazolidinedione therapy in Medicaid type 2 diabetic patients: a retrospective data analysis. Curr Med Res Opin 2004;20(10):1633–40. doi:10.1185/030079904X4789

Correction to: Price D, Haughney J, Lloyd A et al. An economic evaluation of adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study. Curr Med Res Opin 2004;20(10):1671-9. doi:10.1185/030079904X5409

Correction to: Recker R, Masarachia P, Santora A et al. Trabecular bone microarchitecture after alendronate treatment of osteoporotic women. Curr Med Res Opin 2004;21(2):185–94. doi:10.1185/030079904X20259

Correction to: Sebba AI, Bonnick SL, Kagan R et al. Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis. Curr Med Res Opin 2004; 20(12): 2031-41. doi:10.1185/030079904X16768